Hanna Mårtensson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hanna Mårtensson has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Alexandra Stubelius
Division of Chemical Biology, Department of Life Sciences, Chalmers University of Technology, Gothenburg 412 96, Sweden
1 shared publication Fan Jia
Division of Chemical Biology, Department of Life Sciences, Chalmers University of Technology, Gothenburg 412 96, Sweden
1 shared publication- Gizem Erensoy
Division of Chemical Biology, Department of Life Sciences, Chalmers University of Technology, Gothenburg 412 96, Sweden
1 shared publication - Hamza Yakubu
Division of Chemical Biology, Department of Life Sciences, Chalmers University of Technology, Gothenburg 412 96, Sweden
1 shared publication - Loise Råberg
Division of Chemical Biology, Department of Life Sciences, Chalmers University of Technology, Gothenburg 412 96, Sweden
1 shared publication - Ratish Rajgopalan Nair
Division of Chemical Biology, Department of Life Sciences, Chalmers University of Technology, Gothenburg 412 96, Sweden
1 shared publication
Latest Publications
- Open Access
- 10 December 2025
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 14 (3) , 661-683
Advances in phenylboronic acid and phenylboronic ester-based responsive systems for precision medicine
PBA and PBE derived materials have played a crucial role in advanced healthcare technologies such as diagnostics, therapeutics and theranostics that can be useful for personalized therapies based on biomarkers of diseases.
- 10 December 2025
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 14 (3) , 661-683
Open AccessAdvances in phenylboronic acid and phenylboronic ester-based responsive systems for precision medicine
PBA and PBE derived materials have played a crucial role in advanced healthcare technologies such as diagnostics, therapeutics and theranostics that can be useful for personalized therapies based on biomarkers of diseases.